Overexpression of Integrin Linked Kinase (ILK) in intestinal and mammary epithelial cells results in a highly invasive phenotype, associated with increased levels of expression of the matrix metalloproteinase MMP-9. This increase was at the transcriptional level as determined by MMP-9 promoter-CAT reporter assays. Mutations in the two AP-1 binding sites within the MMP-9 promoter completely inhibited the reporter activity. We have previously shown that ILK inhibits glycogen synthase kinase-3 (GSK-3) activity. Transient transfection of wild-type GSK-3b in ILK-overexpressing cells decreased MMP-9 promoter activity and AP-1 activity, indicating that ILK can stimulate MMP-9 expression via GSK-3b and AP-1 transcription factor. A small molecule inhibitor of the ILK kinase reduced the in vitro invasiveness of ILK-overexpressing cells as well as the invasiveness of several human brain tumor cell lines. Furthermore, both MMP-9 promoter and AP-1 activities were inhibited by the ILK inhibitor. Invasiveness of ILK-overexpressing cells was also reduced by inhibition of MMP-9. These data demonstrate that ILK can induce an invasive phenotype via AP-1-dependent upregulation of MMP-9. Oncogene (2000) 19, 5444 ± 5452.
Introduction
Metalloproteinases (MMPs) are a large family of zinc-dependent endopeptidases capable of degrading extracellular matrix (ECM) components (Woessner, 1991) . Although degradation of ECM is essential in many physiological processes (development, cell growth or repair of tissues), it is also a necessary requisite for tumor invasion, metastasis and angiogenesis (Westermarck and Kahari, 1999) . Increased expression of MMPs is associated with tumor invasion and metastasis of malignant tumors (Johnsen et al., 1998) . Two MMPs are closely correlated with metastatic potential: the 72 kDa MMP-2 (gelatinase A) and the 92 kDa MMP-9 (gelatinase B). Both degrade denatured collagens (gelatins) as well as types IV and V collagen present in the basement membrane (Murphy et al., 1989) . Metastatic tumor cell lines express higher levels of gelatinases than nonmetastatic cell lines (Liotta et al., 1980) . Although the two proteinases share structural and catalytic similarities, their gene expression is dierentially regulated, partly due to distinct regulatory elements in their promoters. Transcription of MMP-9 mRNA is regulated by 670 base pairs of upstream sequence (Sato and Seiki, 1993) which includes AP-1, NFkB, PEA3 and SP1 binding sites.
Integrin-linked kinase (ILK) is an ankyrin-repeat containing serine-threonine protein kinase which interacts with the cytoplasmic domains of integrin subunits (Hannigan et al., 1996) . ILK appears to couple integrins and growth factor receptors to downstream signaling pathways involved in the suppression of apoptosis, and in the promotion of cell survival through protein kinase B (PKB/AKT) and glycogen synthase kinase-3b (GSK-3b) Delcommenne et al., 1998) . Phosphatidylinositol-3 kinase (PI-3K)-dependent activation of ILK regulates PKB/AKT by phosphorylation of PKB/AKT on serine 473, resulting in PKB/AKT activation (Delcommenne et al., 1998; Persad et al., 2000) . ILK can also phosphorylate and inhibit the activity of GSK-3b, which then results in the activation of the b-catenin/lef-1 complex (Delcommenne et al., 1998; Novak et al., 1998) as well as the AP-1 transcription factor (Troussard et al., 1999) . Overexpression of ILK in epithelial cells results in anchorage-independent cell survival (Radeva et al., 1997) , increased invasion of extracellular matrices (Novak et al., 1998; Wu et al., 1998) and tumorigenicity in nude mice (Wu et al., 1998) .
In this study we demonstrate that ILK induces the expression of the MMP-9 metalloproteinase. Activation of AP-1 binding sites in the MMP-9 promoter appears to be responsible for the ILK-induced expression of MMP-9. We also show that inhibition of ILK results in the inhibition of the MMP-9 promoter and AP-1 activities, as well as in the inhibition of the ILK-dependent invasive behavior of ILK-overexpressing cells and the invasiveness of several brain tumor cell lines.
Results

Overexpression of ILK stimulates MMP-9 expression
MMP gelatinolytic activity was assessed in various clones of rat intestinal epithelial cells. MMP-9 was only expressed in IEC18 cells stably transfected with ILK in the sense orientation (ILK-13 cells, clones A4a and A1a3) (Hannigan et al., 1996) (Figure 1A ). MMP-9 was not detected in either the parental cell line or the control IEC18 cells stably transfected with ILK in the anti-sense orientation (ILK-14 cells, clones A2c3 and A2c6) (Hannigan et al., 1996) . We have previously described that overexpression of ILK in A4a and A1a3 clones leads to a higher ILK kinase activity (Radeva et al., 1997; Delcommenne et al., 1998) .
We also assessed gelatinolytic activity in the mouse mammary epithelial cell line scp2 as well as in scp2 cells either stably transfected with ILK in the sense orientation (scp2-13) (Novak et al., 1998) or cotransfected with ILK and E-cadherin (scp2-13E) ( Figure 1B ). MMP-9 was speci®cally expressed in the ILK-overexpressing scp2-13 cells while all cell lines expressed MMP-2. In order to determine the ILK kinase activity in these three cell lines, we examined two downstream proteins regulated by ILK, PKB/ AKT and GSK-3b. We have previously described that ILK phosphorylates PKB/AKT on serine 473 and decreases GSK-3b kinase activity (Delcommenne et al., 1998) . In scp2-13 cells ( Figure 1B) , an elevated ILK kinase activity is demonstrated by increased phosphorylation of PKB/AKT on serine 473 and decreased GSK-3b kinase activity. Densitometric analysis of the phosphorylation status of serine 473 on PKB/AKT showed a 2.3-fold higher phosphorylation level ( Figure 1C ). Densitometric analysis of GSK-3b kinase activity revealed that ILK decreased GSK-3b kinase activity by 73% ( Figure 1C ). Ecadherin expression has been shown to be dramatically decreased in ILK-overexpressing scp2 cells (scp2-13) (Novak et al., 1998) . Interestingly, restoration of expression of E-cadherin by transfection in scp2-13 cells (scp2-13E) reversed the ILK-induced changes in MMP-9 expression. scp2-13E cells maintained a pro®le comparable to the parental scp2 cell line ( Figure 1B ). MMPs expression was also determined in scp2 cells stably transfected with ILK using a viral expression vector (scp2-13ILKV1 cells) and in two dierent clones of scp2 stably cotransfected with ILK and E-cadherin (scp2-8E6 and 8E7). MMP-9 was highly expressed in scp2-13ILKV1 cells but was not detected in the parental cell line or the two clones cotransfected with ILK and E-cadherin (scp2-8E6 and 8E7) ( Figure 1D ), con®rming the speci®c expression of MMP-9 in ILK-overexpressing scp2 cells and the reversal of MMP-9 expression by E-cadherin. Figure 1D also shows that ILK overexpression did not signi®cantly alter the expression of MMP-2.
Collectively, these data suggest that ILK overexpression stimulates the expression of MMP-9 and that this correlates with the ILK-induced activation of PKB/AKT and inhibition of GSK-3b.
Regulation of MMP-9 promoter by ILK
In order to evaluate the mechanism by which ILK induces MMP-9 expression, we examined the promoter of MMP-9. The MMP-9 promoter contains several responsive elements which regulate its expression (Sato and Seiki, 1993) , such as two AP-1 binding sites located at 779 and 7533 in the 5'¯anking sequence ( Figure 2A ). Based on our recent ®ndings that ILK regulates AP-1 transcriptional activity (Troussard et al., 1999) , we performed transient transfections of MMP-9 promoter-reporter construct and of MMP-9 promoter cDNA mutated at the two dierent AP-1 binding sites (Figure 2A ), in scp2 and ILK-overexpressing scp2-13 cells. MMP-9 promoter activity was several fold higher (®ve times) in the ILKoverexpressing scp2-13 cells compared to scp2 cells ( Figure 2B ). Mutations in the AP-1 binding sites dramatically decreased the MMP-9 promoter activity in ILK-overexpressing scp2-13 cells, indicating that AP-1 sites are necessary for MMP-9 promoter activity. Since we have recently shown that AP-1 is regulated by ILK through GSK-3b (Troussard et al., 1999) , we examined the eect of GSK-3b on MMP-9 promoter activity. We performed transient transfections of wild type GSK-3b, dominant negative PKB/AKT (AAA-AKT) (Wang et al, 1999) and kinase de®cient ILK (ILK-KD) in ILK-overexpressing scp2-13 cells. As shown in Figure 2c both GSK-3b and PKB/AKT regulate the ILK-induced MMP-9 promoter activity. However, examination of the minimal AP-1 responsive element under the same transfection conditions (Figure 2d ) revealed that, as shown previously (Troussard et al., 1999) , ILK-KD and GSK-3b suppress the ILK-induced AP-1 activity, while AAA-AKT does not.
These data suggest that ILK via GSK-3b is involved in the upregulation of the MMP-9 promoter activity through its AP-1 binding sites.
Inhibition of ILK activity suppresses MMP-9 activity, MMP-9 promoter activity, AP-1 activity and cell invasiveness in ILK-overexpressing cells
We have recently identi®ed highly selective small molecule inhibitors of ILK (Persad et al., 2000) . By gelatinolytic analysis, we evaluated MMP-9 activity after exposure of ILK-overexpressing scp2-13 cells to one of these inhibitors, KP-SD-1 (Persad et al., 2000) . As shown in Figure 3A , inhibition of ILK activity by KP-SD-1 or transient transfection of dominant negative ILK, resulted in a decrease of MMP-9 activity. The same results were obtained in ILKoverexpressing epithelial cells, ILK13 clone A4a (data not shown). Assessment of MMP-9 promoter activity in scp2-13 cells in presence of KP-SD-1 showed a dose dependent inhibition of MMP-9 promoter activity, with a maximum inhibition of 32.4% at 100 mM concentration of inhibitor ( Figure 3B ). Under the same conditions, the minimal AP-1 responsive element activity was decreased by 54.2% by the ILK inhibitor ( Figure 3C ). These results show that ILK can regulate MMP-9 activity and MMP-9 promoter activity probably by its AP-1 binding sites. It is unlikely that the eect of the ILK inhibitor was due to decreased cell viability, as the viability of the cells in presence or in absence of ILK inhibitor was not signi®cantly dierent (data not shown).
We have previously described the invasive phenotype of ILK-overexpressing intestinal epithelial IEC18-13 cells (Hannigan et al., 1996; Novak et al., 1998; Wu et al., 1998) . The invasive behavior of these cells was then assessed in a Matrigel invasion assay in the presence of the ILK inhibitor (KP-SD-1). As expected, in absence of ILK inhibitor, ILK-overexpressing cells were found to be more invasive than the parental cell line (Table  1) . However, presence of ILK inhibitor in the assay completely inhibited the ILK overexpression-induced invasion into Matrigel by IEC18-13 cells.
In order to investigate if MMP-9 activity is required for ILK-stimulated invasion, we evaluated the eect of a synthetic inhibitor of gelatinases, BB-94 (Mira et al., 1999) , on the invasiveness of ILK-overexpressing scp2-13 cells into Matrigel. Morphologically, invasive scp2-13 cells are characterized by long, stellate cellular projections, as shown in Figure 3D (a, DMSO control). In presence of the PI-3-kinase inhibitor LY294002 ( Figure 3D, b) , which is a positive control for invasion inhibition, cells appeared rounded indicating that they did not invade through Matrigel. In presence of the ILK inhibitor KP-SD-1 ( Figure 3D , c) and the MMP inhibitor BB-94 ( Figure 3D, d ), an inhibition of invasion was observed. In order to quantify these inhibitions, cells that did not invade through Matrigel Point mutations in the AP-1 motif at 779 or 7533 generated the 779 AP-1 mutant or the 7533 AP-1 mutant (Sato and Seiki, 1993; Gum et al., 1996) . (B) MMP-9 promoter activity in scp2 and ILK-overexpressing scp2-13 cells was assessed by CAT assay. Cells were transiently transfected with the MMP-9 promoter or with the MMP-9 promoter mutated at one AP-1 binding site (779 or 7533). (C) Eect of transient transfection of ILK-KD, GSK-3b and AAA-AKT on MMP-9 promoter activity in ILK overexpressing scp2-13 cells. Cells were transiently transfected with the indicated plasmids and MMP-9 promoter activity was measured by luciferase assay. ILK-KD expression is shown by Western blot using an anti-V5 antibody; GSK-3b and AAA-AKT expression using an anti-HA antibody. (D) The eect of transient transfection of ILK-KD, GSK-3b and AAA-AKT on the minimal AP-1 responsive element activity was assessed exactly as described for the MMP-9 promoter 3 h after plating were removed by trypsinization, replated onto tissue culture dish and quanti®ed by MTT at 540 nm ( Figure 3D, graph) . As an increase in absorbance represents an inhibition of invasion, it is clear that both KP-SD-1 and BB-94 reduced the invasiveness of ILK-overexpressing cells. Although BB-94 has been described to inhibit MMP-9 and MMP-2 activities (Kolkhorst et al., 1998; Tonn 25 mM) , the ILK inhibitor KP-SD-1 (c, 50 mM) or the metalloproteinase inhibitor BB-94 (d, 100 nM). Cultures were maintained for 24 h and photographed live by phase microscopy (bar=50 mm). Graph is a quanti®cation of scp2-13 cells that did not invade the Matrigel after 3 h of plating. An increase in absorbance is directly proportional to inhibition of invasion. Each experiment was performed in triplicate, means+s.e.m. *P50.05 vs DMSO control et al., 1999), it is unlikely that MMP-2 is involved in the inhibition of invasion of ILK-overexpressing cells by BB-94 since MMP-2 is expressed in both the noninvasive parental scp-2 cells and the invasive ILKoverexpressing cells, whereas MMP-9 is exclusively expressed in the invasive ILK-overexpressing cells.
Since inhibition of ILK resulted in decreased MMP-9 expression, MMP-9 promoter activity and ILKinduced cell invasion, and inhibition of MMP-9 resulted in reduced cell invasion of Matrigel by ILKoverexpressing cells, we propose that the ILK-induced MMP-9 expression may be responsible for the ILKinduced invasive phenotype of ILK-overexpressing cells.
Inhibition of ILK in human glioblastoma U251 cells
We next determined whether the inhibition of ILK activity in highly invasive brain tumor cell lines would also result in inhibition of tumor cell invasion. For several brain tumor cell lines (human glioblastoma U251 cells, rat astrocytes glioma C6 cells, human medulloblastoma Daoy, UW3 and UW2 cells), invasiveness in absence or presence of 50 mM ILK inhibitor was assessed in a 3-dimensional invasion assay coupled with video microscopy. Invasion was inhibited by the ILK inhibitor in the ®ve brain tumor cell lines ( Table  2 ). Inhibition of invasion by KP-SD-1 was dosedependent as shown for one of the cell lines, the human glioblastoma U251 cells ( Figure 4A ). The eect of the ILK inhibitor was then evaluated on the ILK kinase activity in U251 cells by assessing the status of phosphorylation of PKB/AKT on serine 473 (Delcommenne et al., 1998; Persad et al., 2000) , and the ability of ILK to phosphorylate MBP (Delcommenne et al., 1998) . Phosphorylation of serine 473 as well as phosphorylation of MBP were decreased in a dose dependent manner by the ILK inhibitor ( Figure 4B ), indicating that ILK kinase activity in U251 cells was inhibited by KP-SD-1. Densitometric analyses showed that 100 mM of inhibitor reduced phosphorylation of AKT-ser473 by 53% and phosphorylation of MBP by 39.4% (data not shown).
It has been reported that U251 cells expressed MMP-9 (Rao et al., 1994) . As shown in Figure 4C , MMP-9 expression was inhibited both by incubation with KP-SD-1 and by transfection of dominant negative ILK-KD. Densitometric analyses showed that MMP-9 expression was inhibited by 47% with 100 mM of KP-SD-1 and by 49% with transfection of ILK-KD (data not shown). Furthermore, MMP-9 promoter activity in U251 is also decreased by the ILK inhibitor (41% of inhibition at 100 mM) ( Figure 4D ). The data presented in Figure 4 show that MMP-9 dependent invasiveness of U251 brain tumor cells is linked to ILK.
Collectively, our data demonstrate that the inhibition of ILK results in a substantial inhibition of invasiveness and MMP-9 activity, possibly through downregulation of AP-1 transcription factor by the ILK target GSK-3b in the MMP-9 promoter.
Discussion
In epithelial cells, overexpression of ILK leads to a ®broblastoid and invasive phenotype (Hannigan et al., 1996; Novak et al., 1998; Wu et al., 1998) . This is associated with down-regulation of E-cadherin expression (Novak et al., 1998; Wu et al., 1998) . It has been shown previously that loss of expression of the cell adhesion molecule E-cadherin is correlated with increased MMP-9 expression in invasion and metastasis (Sato et al., 1999; Llorens et al., 1998; Luo et al., 1999) . We now report that overexpression of ILK in rat intestinal epithelial IEC18 cells as well as in mouse mammary epithelial scp2 cells results in increased MMP-9 expression. Similar results have recently been described in the metastatic HT-144 melanoma cells in which high level of ILK expression is correlated with high MMP-9 expression and low E-cadherin expression (Janji et al., 1999) . In this study we have demonstrated that ILK stimulates MMP-9 by regulating its promoter. The MMP-9 promoter contains several responsive elements that have been shown to regulate its expression. For instance, expression of MMP-9 gene is transcriptionally regulated via AP-1, NF-kB and Sp-1 by extracellular factors such as TPA and TNFa (Sato and Seiki, 1993) . Participation of the MAPK pathway has been described in the regulation of MMP-9 expression by JNK-and ERK-dependent signaling cascades (Gum et al., 1997) or by p38 MAPK pathway (Simon et al., 1998) . We have recently shown that although AP-1 can be regulated via JNK activation, cell-extracellular matrix interactions via ILK can independently regulate AP-1 transcriptional activity through GSK-3b (Troussard et al., 1999) . Experiments using inactivating point mutations at 779 and 7533 of the MMP-9 promoter were carried out and the ILKinduced MMP-9 promoter activity was completely suppressed by these mutations. We can therefore say that the AP-1 binding sites in the MMP-9 promoter are necessary for the ILK-induced MMP-9 promoter activity. Both GSK-3b and PKB/AKT are able to regulate MMP-9 activity but only GSK-3b aects AP-1 activity. The eect of PKB/AKT on the MMP-9 promoter was probably not through AP-1, but through another transcription factor present in the promoter. Indeed, it has been described that NF-kB is a target of PKB/AKT (Romashkova and Makarov, 1999; Ozes et al., 1999) . We therefore propose that ILK can activate the MMP-9 promoter, and consequently MMP-9 expression, through the GSK-3b/AP-1 pathway described by us recently (Troussard et al., 1999) . In addition, inhibition of ILK kinase activity in ILKoverexpressing cells results in the inhibition of MMP-9 promoter as well as AP-1 activities, further demonstrating that ILK regulates MMP-9 promoter through its AP-1 responsive elements.
Of interest in our ®nding that the inhibition of ILK activity by a speci®c small molecule inhibitor suppresses tumor cell invasion, providing strong evidence for a central role of ILK in the regulation of cell invasion. This role is emphasized by the inhibition of invasiveness, ILK kinase activity and MMP-9 activity observed in the human glioblastoma U251 cells in the presence of the ILK inhibitor. Overexpression of ILK or the constitutive activation of ILK, for example in PTEN-mutant tumors (Persad et al., 2000; Morimoto et al., 2000) , may play a central role in tumor cell progression towards an invasive phenotype via AP-1 dependent upregulation of MMP-9. Inhibition of ILK activity may therefore be of therapeutic value in the control of tumor progression.
Materials and methods
Stably transfected cell lines
Clones of IEC18 intestinal epithelial cell expressing either wild-type ILK cDNA in the sense orientation (ILK13 cells; clones A4a and A1a3) or anti-sense orientation (ILK14 cells; clones A2c3 and A2c6) were established as described by us (Hannigan et al., 1996) . All clones and the parental cell line were maintained in a-MEM containing 5% FBS, insulin (10 mg/liter) and glucose (3.6 g/liter). The transfected clones were also maintained in 40 mg/ml G418 to provide selection pressure. Mouse mammary epithelial cells scp2 were maintained in DMEM/F12 containing 5% FBS, insulin (5 mg/ liter) and gentamycin sulphate (5 mg/liter). Additionally, scp2 cells stably transfected with wild-type ILK cDNA in the sense-orientation (scp2-13) (Novak et al, 1998) or wild-type ILK and E-cadherin cDNAs in the sense-orientation (scp2-13E) were maintained in G418 (80 mg/ml). For retroviral infection, wild-type ILK-V5 cDNA was subcloned into MSCV vector, then transfected into the BOSC-29 packaging cells. Filtered viral supernatants were used to infect subcon¯uent scp2 cells. After 48 h, cells were selected using puromycin (2 mg/ml) for 5 days. Selected cells were maintained in media containing puromycin (2 mg/ml).
DNA transfection and reporter gene assay scp2 cells were transiently transfected using Fugene transfection reagent (Boehringer Mannheim) with 1 mg of plasmid. The following cDNAs were used: His-V5-tagged kinasede®cient ILK (pcDNA3.1-ILK-KD-V5), HA-tagged wildtype GSK-3b (pcDNA3-GSK-3-HA), HA-tagged kinasede®cient AKT (pcDNA-AAA-AKT-HA) (Wang et al., 1999) , minimal AP-1 responsive element-luciferase reporter gene (pGL3-AP-1) (construct containing exclusively AP-1 binding sites, Troussard et al., 1999) , MMP-9 promoterluciferase or CAT reporter gene as well as two mutants of MMP-9 promoter AP-1 binding sites (kindly provided by D Boyd). Point mutations of the 670 bp MMP-9 promoter sequence in the AP-1 motif at 7533 generated the 7533 AP-1 mutant (described by Gum et al., 1996) , and point mutations in the AP-1 motif at 779 generated the 779 AP-1 mutant (described by Sato and Seiki, 1993) . MMP-9 promoter activity was assessed by dual-luciferase assay (Promega) or CAT Elisa assay (Boehringer Mannheim), and AP-1 activity by dual-luciferase assay. Activities were evaluated 36 h after cotransfection of the speci®c reporter plasmid and the control reporter (Renilla). Thereafter, MMP-9 promoter activity and AP-1 activity were normalized in reference to the activity of the Renilla control. Protein concentrations were determined by Bradford assay.
Zymography
Gelatinolytic activities of MMP-2 and MMP-9 were evaluated as described previously (Gum et al, 1997) . For Figure 1A ,D, 24 h conditioned media from 10 5 cells were resolved on a 10% polyacrylamide gel containing 0.1% (w/v) gelatin. The gels were washed in 2.5% TritonX-100. After overnight incubation at 378C in 50 mM Tris (pH 7.5); 10 mM CaCl 2 ; 0.15 M NaCl, the gels were stained with 0.5% Coomassie blue. Proteolysis was detected as a white zone in a dark ®eld.
For Figures 3A and 4C , after transfection or treatment with the ILK inhibitor KP-SD-1 for 48 h, media from the last 24 h were concentrated three times (centricon columns from Millipore). Gelatinases were activated by incubation with 1 mM APMA (p-aminophenylmercuric acetate, Sigma) for 6 h at 378C. Samples were then resolved on polyacrylamide gel as described above.
Immunoblots
Protein extracts were resolved by SDS ± PAGE electrophoresis and the proteins were electrotransferred onto Immobilon-P membranes (Millipore). The membranes were then probed with the appropriate primary antibody: anti-ILK (Upstate Biotechnologies), anti-AKT (New England Biolabs), anti-AKT-ser473-P (New England Biolabs), anti-E-cadherin (Transduction laboratories), anti-HA (Covance) or anti-V5 (Invitrogen). Protein detection was carried out using an HRP-conjugated secondary antibody and an ECL detection system (Amersham Pharmacia).
GSK-3 kinase assay
Equivalent protein concentrations of cell lysates were immunoprecipitated with an anti-GSK-3b antibody, and the kinase assay was performed as described previously (Delcommenne et al, 1998) , using glycogen synthase-1 peptide (GS-1) as a substrate for GSK-3b. Phosphorylated GS-1 was detected after electrophoresis on a Tricine gel, and visualized by autoradiography. Autoradiographic signals were quanti®ed by densitometric analysis (BioRad Laboratories).
ILK kinase assay
Equivalent protein concentrations of cell lysates were precleared with non speci®c IgG bound to protein Asepharose. Supernatants were immunoprecipitated with an anti-ILK antibody. As previously described (Delcommenne et al., 1998) , myelin basic protein (MBP) was used as a substrate for ILK. Phosphorylated MBP was detected after electrophoresis on a SDS-15% polyacrylamide gel and visualized by autoradiography. Autoradiographic signals were quanti®ed by densitometric analysis (BioRad Laboratories).
Invasion assays
Collagen 3-dimensional invasion assays, coupled with video microscopy, were performed for brain tumor cell lines as described previously (Tamaki et al, 1997) . The ILK inhibitor, KP-SD-1, was incorporated in the collagen. For the Matrigel invasion assay (Table 1) (Novak et al, 1998) , the cells were applied to the upper chambers in media containing the ILK inhibitor KP-SD-1. For Figure 3D , ILK-overexpressing scp2-13 cells were plated on reconstituted basement membrane gels (Matrigel, Collaborative Res.) at a density of 5610 4 /cm 2 . The indicated treatments were present both in the serum-free medium and the basement membrane. Morphologically, invasion was assessed as the ability to migrate into the gel by forming long, stellate cellular projections after 24 h. Any inhibition of invasion was also quanti®ed by determining the number of cells that did not enter the Matrigel 3 h after plating. Attached but uninvaded cells were removed by treating the cultures 15 min with 0.125% trypsin. These cells were then replated into separate tissue culture plastic plates and the viable, re-attached cells were assayed by the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide cleavage assay (MTT, absorbance at 540 nm; Mosmann, 1983) . Thus, this assay rules out inhibition of invasion due to nonspeci®c cytotoxicity or cell detachment.
